X4 Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell XFOR and other ETFs, options, and stocks.

About XFOR

X4 Pharmaceuticals, Inc. is a late clinical-stage company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. Its clinical candidate is mavorixafor.

CEO

Paula S. Ragan

CEOPaula S. Ragan

Employees

143

Employees143

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2010

Founded2010

Employees

143

Employees143

XFOR Key Statistics

Market cap

33.00M

Market cap33.00M

Price-Earnings ratio

-1.05

Price-Earnings ratio-1.05

Dividend yield

—

Dividend yield—

Average volume

1.84M

Average volume1.84M

High today

$0.205

High today$0.205

Low today

$0.1893

Low today$0.1893

Open price

$0.1981

Open price$0.1981

Volume

572.34K

Volume572.34K

52 Week high

$1.39

52 Week high$1.39

52 Week low

$0.1876

52 Week low$0.1876

X4 Pharmaceuticals

Why Robinhood?

X4 Pharmaceuticals, Inc. is a late clinical-stage company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. Its clinical candidate is mavorixafor. Show more

XFOR Key Statistics

X4 Pharmaceuticals, Inc. is a late clinical-stage company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. Its clinical candidate is mavorixafor.